Even among patients with unresectable esophageal cancer, long-term survivors had a measurable rate of SPMs. This highlights the importance of post-treatment surveillance for SPMs.
WATANABE et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: